Examkin

Question

Difficulty: MediumDepressive Disorders

A 38-year-old female presents to the clinic with an 8-week history of depressed mood, significant weight loss, early morning awakenings, and severe anhedonia, causing her to take a leave of absence from work. Over the subsequent 14 months, her clinical condition progresses through multiple phases of treatment resistance, eventually culminating in a psychiatric admission for active suicidal ideation with a specific plan. Arrange the following clinical actions in the correct chronological sequence according to evidence-based management guidelines for this patient's evolving condition, from her initial presentation through her eventual inpatient admission.

  1. 1Screen for a lifetime history of elevated mood, impulsivity, or decreased need for sleep prior to prescribing pharmacotherapy.
  2. 2Initiate an SSRI and maintain the therapeutic dose for a minimum of 4 to 6 weeks before assessing for full efficacy.
  3. 3Cross-taper to a serotonin-norepinephrine reuptake inhibitor (SNRI) upon observing zero clinical improvement from the initial medication.
  4. 4Add an augmenting agent such as a second-generation antipsychotic after observing only a partial response to the SNRI.
  5. 5Initiate electroconvulsive therapy (ECT) following acute clinical deterioration characterized by active suicidality.

Answer

The correct sequence begins with screening for bipolar disorder, followed by an adequate SSRI trial, switching to an SNRI due to non-response, augmenting the SNRI for partial response, and finally utilizing ECT for the emergent, refractory suicidal crisis.
The standard psychiatric algorithm for MDD requires a systematic escalation. Safety is the first priority, making bipolar screening the required initial action. Next, an adequate trial of a first-line agent (SSRI) is necessary, avoiding premature discontinuation. If there is no response, switching to another monotherapy (SNRI) is indicated. If that subsequent trial yields only a partial response, augmentation (e.g., atypical antipsychotic) is added. Finally, if the patient becomes refractory and develops life-threatening features (active suicidality), emergency intervention with ECT is the definitive treatment of choice.

Step-by-Step Solution

1
Screen for a history of mania or hypomania.
Bipolar disorder is ruled out.
Administering unopposed antidepressants to a patient with bipolar disorder can precipitate a manic episode. Screening is the absolute first step.
2
Initiate first-line SSRI monotherapy for 4 to 6 weeks.
Patient completes an adequate trial with no clinical response.
Antidepressants take time to downregulate receptors and exhibit clinical effect; a 4-6 week trial prevents premature drug discontinuation.
3
Switch to a different monotherapy class (e.g., SNRI).
Patient achieves only a partial response after another adequate trial.
When there is zero response to a first-line agent, switching to a different medication is standard protocol.
4
Augment the SNRI with a second-generation antipsychotic.
Patient eventually deteriorates despite combination therapy, becoming acutely suicidal.
Augmentation is preferred when a patient has a partial response to avoid losing the slight improvements gained.
5
Admit to psychiatry and administer ECT.
Rapid stabilization of the life-threatening crisis.
ECT provides the most rapid and effective response for severe, treatment-resistant depression with acute suicidality.

Key Concept

Stepped-care management of Major Depressive Disorder, from initial safety screening through adequate medication trials, to emergency neuromodulation.
Rate this question

Topics

Depressive Disorders

More questions from this topic